NCT06368037View on ClinicalTrials.gov

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Obstructive Hypertrophic Cardiomyopathy
Interventions
DEVICE

DragonFire Transcatheter Myocardial Radiofrequency Ablation System

The patients with hypertrophic obstructive cardiomyopathy were treated with a transcatheter myocardial radiofrequency ablation system and its guiding system under the guidance of echocardiography

Trial Locations (1)

Unknown

Northern Theater Command General Hospital of the Chinese People's Liberation Army, Shenyang

All Listed Sponsors
lead

Hangzhou Valgen Medtech Co., Ltd

INDUSTRY